Order Article Reprints

Nemati F, de Koning L, Gentien D, Assayag F, Henry E, Ait Rais K, Pierron G, Mariani O, Nijnikoff M, Champenois G, et al. Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study. Current Oncology. 2023; 30(10):9090-9103. https://doi.org/10.3390/curroncol30100657

Nemati, Fariba, Leanne de Koning, David Gentien, Franck Assayag, Emilie Henry, Khadija Ait Rais, Gaelle Pierron, Odette Mariani, Michèle Nijnikoff, Gabriel Champenois, and et al. 2023. "Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study" Current Oncology 30, no. 10: 9090-9103. https://doi.org/10.3390/curroncol30100657

Nemati, F., de Koning, L., Gentien, D., Assayag, F., Henry, E., Ait Rais, K., Pierron, G., Mariani, O., Nijnikoff, M., Champenois, G., Nicolas, A., Meseure, D., Gardrat, S., Servant, N., Hupé, P., Kamal, M., Le Tourneau, C., Piperno-Neumann, S., Rodrigues, M., ... Cassoux, N. (2023). Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study. Current Oncology, 30(10), 9090-9103. https://doi.org/10.3390/curroncol30100657